…more. Artificial Intelligence and Machine Learning Techniques in Drug Discovery A session from Lonza and the Swiss Data Science Center will set the scene for the track by asking a…
A molecular machine, which plays an essential ‘cargo’ role in controlling the delivery of proteins to the surface of human cells has been identified using artificial intelligence (AI). The research…
…Clinical applications of artificial intelligence and mathematical oncology This special minisymposia, co-chaired by Kristin Swanson and Heiko Enderling, featured the following presentations: Cancer cells subvert fibroblast function to promote a…
…to the patients who need it as fast as possible.” Endogena’s artificial intelligence-driven drug discovery platform, combined with cutting-edge knowledge of molecular pathways that regulate retinal stem cells and retinal…
…cells get their energy, drug repurposing, how artificial intelligence can help provide greater insights into personalised treatments, and ketogenic diet research. Visit https://www.braintumourresearch.org/fundraise/wear-a-hat-day to find out more and make a…
…neoantigen-based vaccines have shown robust tumour-specific immunogenicity and preliminary evidence of antitumour activity. According to GlobalData’s Pharma Intelligence Center, there are currently four personalised cancer vaccines in clinical development in…
…believes the lab of the future will look like. In the second article, Daniel Rines, Senior Director at Strateos, shared how his role, artificial intelligence (AI), the work of Strateos…
…was near death, completely immobile and fully dependent on artificial ventilation. The patient has now been treated with the medication (orally, three times a week) for more than a year,…
…therapeutics. The project uses Oxford Drug Design’s artificial intelligence (AI) computational platform consisting of multiple computational drug discovery capabilities for both ligand- and structure-based design, together with PhoreMost’s SITESEEKER phenotypic…
…main types of primary bone cancer. Artificial sweetener dampened T cell response in mice Scientists at the Francis Crick Institute have found that high consumption of a common artificial sweetener,…
Scientists at the Francis Crick Institute have found that high consumption of a common artificial sweetener, sucralose, lowers activation of T cells in mice. If found to have similar effects…
Charles River Laboratories and Pioneering Medicines have entered a multi-programme agreement that gives Pioneering Medicines access to artificial intelligence (AI) model Logica. Through the agreement, Pioneering Medicines will apply Logica…
…a range of expertise and advanced bioinformatics, automation and artificial intelligence technologies to speed up the development of new treatments. The top stories: X-Chem and Kymera expand partnership to 12…
A new multi-year strategic partnership between M2GEN and Zephyr AI will leverage clinicogenomic data, bioinformatics, and artificial intelligence to accelerate drug discovery and expanded use cases for oncology treatments. In…
…(EIC) Accelerator Fund for its PhageDiag project. The project is a phagogram using artificial intelligence (AI) that enables decentralised diagnostics and personalised treatment. According to the World Health Organization (WHO),…
